News

  • 6 August, 2021 - Press notes

    $200,000 grant for lung cancer research at Hospital del Mar

    $200,000 grant for lung cancer research at Hospital del Mar The team led by Dr. Edurne Arriola and Dr. Beatriz Bellosillo will receive a grant from Thermo Fisher Scientific for their research on the application of liquid biopsy in patients with metastatic small cell lung cancer. The aim is to determine new treatment and prognostic biomarkers in patients with this type of tumour. They will also look for possible new therapeutic targets. This innovative project is one of four selected from around the world to be promoted within the Oncomine Clinical Research Grant programme, and it will look at data from 300 patients with this pathology.

    more information

  • 10 August, 2021 - Press notes

    Dr. Miguel Pera, one of the ten best digestive surgeons practising in Catalonia, according to the list of the Institute of Governance and Applied Economics Coordinates

    Dr. Miguel Pera, one of the ten best digestive surgeons practising in Catalonia, according to the list of the Institute of Governance and Applied Economics Coordinates The Director of the Healthcare and Medical Area, head of the General and Digestive Surgery Service and co-coordinator of the Clinical and Translational Research Group on Colorectal Neoplasms at the Hospital del Mar Medical Research Institute, is one of the top specialists among Catalan digestive surgeons.

    more information

  • 29th July, 2021 - Press notes

    Mechanism that triggers brain neurone response revealed

    Mechanism that triggers brain neurone response revealed Researchers at the Hospital del Mar Medical Research Institute have shown for the first time how small areas of proteins on the surface of neurones control cell response by binding to neurotransmitters. Evolution has led to the existence of proteins with variations in these areas, capable of causing different cellular responses. This makes it possible to precisely regulate the neurone's response to the same neurotransmitter. It paves the way for the development of specific molecules that block areas linked to certain mental illnesses, such as schizophrenia, or to addictive behaviour. It is the first time it has been possible to see how neurotransmitters and proteins interact at the atomic level to trigger neuronal responses. The study has been published in the journal Chemical Science.

    more information

  • 21th July, 2021 - Press notes

    Having higher levels of omega-3 acids in the blood increases life expectancy by almost five years

    Having higher levels of omega-3 acids in the blood increases life expectancy by almost five years A 1% increase in this substance in the blood is associated with a change in mortality risk similar to that of quitting smoking. Conversely, being a smoker cancels out the positive effect of eating oily fish, the main source of omega-3 acids. The study, published in The American Journal of Clinical Nutrition, analysed data from more than 2,000 people participating in a population-based follow-up programme in the United States. Their progress has been studied over an eleven-year period. The researchers will try to validate the data using a European population.

    more information

  • 15th July 2021 - Press notes

    The Anti-Doping Laboratory of Catalonia collaborates with the Tokyo Olympic Laboratory

    The Anti-Doping Laboratory of Catalonia collaborates with the Tokyo Olympic Laboratory Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23.

    more information

  • 13th July 2021 - Press notes

    A new approach to metastatic melanoma discovered

    A new approach to metastatic melanoma discovered Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumour, which has no cure in the most advanced stages or cases of relapse.

    more information

  • July 8th 2021 - Press notes

    Record funding for the Hospital del Mar Medical Research Institute from the Healthcare Research Projects at the Carlos III Institute of Health

    Record funding for the Hospital del Mar Medical Research Institute from the Healthcare Research Projects at the Carlos III Institute of Health The IMIM has obtained nearly 3.4 million euros in financing from this fund, 12% more than in the 2019 call for proposals, the most recent prior to the pandemic. 60% of the proposals submitted were approved, a record number in the history of the institution.

    more information

  • 22nd June, 2021 - Press notes

    More than 6% of Europeans suffer from depression

    More than 6% of Europeans suffer from depression A study in 27 European countries led by researchers from King's College London and the Hospital del Mar Medical Research Institute puts the prevalence of depression at 6.4% of the population. The work, published in The Lancet Public Health, analysed data from the European Health Interview Survey, which includes responses from more than 250,000 people. The incidence is higher in women at 7.7 per cent, while in men it is 4.9 per cent. Strong differences are seen between countries, with higher rates in more economically developed states.

    more information

  • June 15 th, 2021 - Press release

    Launch of European research into radiotherapy for cardiac arrhythmias

    Launch of European research into radiotherapy for cardiac arrhythmias On June 15th and 16th, the STOPSTORM consortium coordinated by the UMC Utrecht with the IMIM and Hospital del Mar's participation, met virtually to discuss early project progress. The project, which officially started on May 1st, will begin researching the use of radiotherapy in treating cardiac arrhythmias. Patients who suffer from ventricular tachycardia (fibrillation of the ventricles) are often treated with medication and/or implantation of an ICD, a defibrillator that corrects a rapid heart rate with an electric shock. In cases of persistent arrhythmias that do not respond adequately to regular therapy, patients may undergo invasive catheter ablation.

    more information

  • June 17th, 2021 - Press notes

    Research finds that COVID-19 vaccines pre-prepared in syringes for their administration can be safely transported

    Research finds that COVID-19 vaccines pre-prepared in syringes for their administration can be safely transported Researchers from the Hospital del Mar and Pompeu Fabra University have confirmed that messenger RNA vaccines pre-prepared in syringes for their administration can be transported by road for up to three hours. This may be of great relevance in mass vaccination strategies, especially in rural and less developed areas, as the doses can be prepared in an official healthcare centre and then transported to remote vaccination sites or areas with an underdeveloped healthcare infrastructure. The researchers have conducted stress tests on syringes pre-prepared for administering the Pfizer BioNTech and Moderna vaccines, and have found that the vector these vaccines use, the messenger RNA, maintains its integrity despite being subjected to movement. The findings have been published in the medical journal Clinical Microbiology and Infection.

    more information

Social commitment

  • Social commitment
Collaborating entity

© 2006 - 2024 Parc de Salut Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility